Bayer – Addressing Disparities in Access to Quality Cancer Care in Underserved Communities
Chitkala Kalidas, PhD, Vice President and Global Head, Oncology Regulatory Affairs and Oncology Sustainability at Bayer discusses the Oncology Sustainab...
5347 articles
Chitkala Kalidas, PhD, Vice President and Global Head, Oncology Regulatory Affairs and Oncology Sustainability at Bayer discusses the Oncology Sustainab...
Ali Tavakkoli, Chief of the Division of General and GI Surgery, co-director of the Center for Weight Management and Wellness, and director of the minima...
Eli Frakes, PhD, Scientific Director of Women's Health in US Medical Affairs at AbbVie discusses data that AbbVie presented at the American College of O...
Leif Pedersen, president of software at Certara, a global leader in biosimulation, discusses the company’s partnership with Chemaxon, a leading chemin...
Greg Sturmer, President and CEO of Elysium Therapeutics discusses the company's mission to reduce suffering from severe acute pain, opioid-use disorder,...
Medical Lead, Rare Disease at UCB discusses positive efficacy and safety results from two phase 3 studies evaluating zilucoplan, a self-administered, su...
Keyan Salari, a urologic oncologist and surgeon, Co-Director, Prostate Cancer Genetics Program at Massachusetts General Hospital discusses his study "Im...
Cory Rice, Medical Director for Biote's training clinic and research facility discusses longevity precision medicine and bioidentical hormone replacemen...
Chris Round, President of EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. Learn more on Health Professional Radio.
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...